Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Acute Hepatitis C Virus in HIV Co-Infection
NCT00845676Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by University of California, San Francisco. Started Mar 2008; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00845676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845676.